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Abstract
Background: Blood vessels comprise endothelial cells, mural cells (pericytes/vascular smooth muscle cells) and basement
membrane. During angiogenesis, mural cells are recruited to sprouting endothelial cells and define a stabilizing context,
comprising cell-cell contacts, secreted growth factors and extracellular matrix components, that drives vessel maturation
and resistance to anti-angiogenic therapeutics.
Methods and Findings: To better understand the basis for mural cell regulation of angiogenesis, we conducted high
content imaging analysis on a microtiter plate format in vitro organotypic blood vessel system comprising primary human
endothelial cells co-cultured with primary human mural cells. We show that endothelial cells co-cultured with mural cells
undergo an extensive series of phenotypic changes reflective of several facets of blood vessel formation and maturation:
Loss of cell proliferation, pathfinding-like cell migration, branching morphogenesis, basement membrane extracellular
matrix protein deposition, lumen formation, anastamosis and development of a stabilized capillary-like network. This
phenotypic sequence required endothelial-mural cell-cell contact, mural cell-derived VEGF and endothelial VEGFR2
signaling. Inhibiting formation of adherens junctions or basement membrane structures abrogated network formation.
Notably, inhibition of mural cell VEGF expression could not be rescued by exogenous VEGF.
Conclusions: These results suggest a unique role for mural cell-associated VEGF in driving vessel formation and maturation.
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Introduction
Mural cells, a peri-endothelial localized mesenchymal cell type
including vascular smooth muscle cells and pericytes, exert a
dominant effect on endothelial cell behavior, driving vessel
maturation, regulating vascular function and influencing respon-
siveness to anti-angiogeneic therapeutics [1–4]. Maturation of
blood vessels is a stepwise transition from an actively growing
vascular bed to a quiescent functional network [5]. This entails
strict temporal and spatial coordination of endothelial cell
signaling pathways that govern proliferative, migratory and
morphogenic endothelial phenotypes [6]. The recruitment of
mural cells to the abluminal surface of nascent blood vessels is a
key prerequisite for vessel maturation. Mural cells define a context
comprising heterotypic cell-cell contacts, ECM deposition and
soluble factors that inhibits endothelial proliferation, maintains
capillary diameter, regulates blood flow and provides survival
signals [7].
Prior to mural cell coverage, nascent vessels are susceptible to
remodeling and VEGF-signaling inhibitors [1]. Genetic and
pharmacological inhibition of PDGFR-b reduces mural cell
recruitment to growing vessels and is associated with exacerbated
angiogenesis, endothelial hypertrophy and irregular, enlarged
vessels [8,9]. Interestingly, endothelial cell VEGF expression can
alter mural cell responsiveness to PDGF via growth factor
crosstalk, modulating mural cell recruitment and mural function
[10]. Abnormal mural cell interactions in tumor vasculature
contribute to the presence of non-perfused vessels, aberrant vessel
size, loss of the hierarchical vessel organization and sensitivity to
anti-angiogenic agents [11].
Heterotypic cell-cell contact at interdigitations between endo-
thelial cells and mural cells provides a unique presentation context
for paracrine factors such as VEGF and angiopoietins that
regulate endothelial cellular responses [4,10,12]. Mural-endothe-
lial cell-cell contact leads to TGF-b1 activation, which in turn
inhibits endothelial cell proliferation, while inducing differentia-
tion of mesenchymal stem cells into pericytes [13,14]. An
important system governing vessel maturation is endothelial Tie2
receptor activation by mural cell Ang-1 [15,16]. Angiopoietin-
Tie2 signaling, where endothelial Ang-2 competes with mural cell-
derived Ang-1, controls endothelial responsiveness to VEGF and
angiogenic remodeling [17,18]. Indeed, differential requirements
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5798for VEGF in immature and mature vessels accounts for the
observed vascular ‘‘normalizing’’ effect of VEGF signaling
inhibitors in clinical use [19,20].
In spite of the central role that mural cells play in determining
vascular maturation and anti-angiogenic therapeutic responses,
our understanding of the molecular mechanisms mediating these
effects is incomplete. In vitro organotypic angiogenesis models, such
as the co-culture of primary endothelial (umbilical vein EC or
microvascular EC) and mural cells (pericytes, vascular smooth
muscle cells (vSMC), fibroblasts, mesenchymal stem cells) in two-
and three-dimensional (imbedded in extracellular matrix) assays
[21], have been used to study heterotypic interactions required for
EC-mural cell crosstalk [6,13,14,18,22–28]. We adapted EC-
mural cell co-culture to a microtiter plate format to facilitate high
throughput interrogation of mural cell-dependent regulation of
endothelial cell behaviors by combined chemical genetic manip-
ulation and quantitative high content imaging techniques. Using
this approach we reveal that this high throughput screening
(HTS)-compatible EC-mural cell co-culture system recapitulates a
remarkable assortment of angiogenic endothelial cell behaviors.
Mural cells define a context in co-culture that enables an
endothelial cellular program resulting in formation of a capil-
lary-like network, via a predictable sequence of phenotypic
changes reflective of several facets of angiogenesis and vessel
maturation: i) loss of EC proliferation; ii) pathfinding cell
migration; iii) adherens junction formation; iv) branching
morphogenesis and network formation; v) vascular basement
membrane-like formation, collagen IV/XVIII ensheathment; vi)
patent lumen formation; vi) anastamosis and vii) network
stabilization. Our findings emphasize a key role for mural cell
presentation of VEGF to drive vessel formation and maturation.
Results
ECs co-cultured with vSMCs or mesenchymal stem cells
form capillary-like networks
To study how mural cells affect endothelial cell behavior we
used a genetically and pharmacologically tractable in vitro model
system comprising co-cultured primary human endothelial and
vascular smooth muscle (EC-vSMC) cells [29]. During a one-week
period primary human ECs co-seeded with vSMCs in microtiter
plates undergo a predictable series of phenotypic changes that
result in a stable, interconnected network (Figure 1A-B). Elongated
ECs interdigitate to form capillary-like tubular structures of
uniform diameter (Figure 1C). Co-cultured EC and vSMC cells
rapidly self-organize into two distinct layers, vSMCs forming a
confluent layer on the culture dish surface and ECs above
(Figure 1D). Impeding this cellular self-organization by pre-
Figure 1. Endothelial cells in co-culture with vascular smooth muscle cells generate capillary-like networks. (A) Live cell fluorescence
microscopy of GFP-expressing HUVEC cell capillary-like network (green) after 5 days in co-culture with PA-vSMC (unlabeled). (B) Mixed RFP- and GFP-
expressing HUVEC (1:1) in co-culture with PA-vSMC (unlabeled) at Day 9 demonstrate extensive interaction between ECs within network. (C) Two-
color HUVEC networks (9 days) comprise uniform elongated, inter-digitating ECs. (D) Confocal fluorescence microscopy analysis (z-stack) of RFP-
expressing HUVEC and GFP-expressing PA-vSMC co-cultures show cells self-organize into distinct layers with ECs residing atop a confluent vSMC
layer. (E) Cells grown in co-culture allowing cell-cell contact results in a capillary-like network. (F) Co-cultures in separated by a porous membrane in
transwell chambers do not form a network. (G) Temporal image analysis during 6 days of EC network formation shows a decrease in the number of
non-networked cells as EC connectivity is established and stabilizes. (H) Lumens form at branch points (inset: z-stacks) and throughout the EC
network. (I) TRITC-dextran (10 000 MW) concentrates into patent lumens in Day 9 endothelial networks (inset: z-stacks).
doi:10.1371/journal.pone.0005798.g001
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plating, blocked EC network formation (data not shown).
Heterotypic cell contact was required as neither vSMC-condi-
tioned medium alone nor co-culture in transwell chambers
resulted in EC network formation (Figure 1E-F; data not shown).
vSMC monolayers fixed by a variety of methods (e.g cross-linking
agents, freeze-thaw) also do not induce EC network formation
(data not shown). Time-lapse video fluorescence microscopy
analysis revealed that the formation of EC networks progresses
through distinct phases (Figure 1G and Video S1). ECs
immediately stop dividing and during the first 48 hours become
elongated and highly migratory. Migrating ECs form ‘‘cell trains’’
and branched junctions eventually enlisting nearly every cell into
the final network (Figure 1G). Once formed, these networks
stabilize, ceasing migration (Video S2) and form a patent lumen
structure that concentrates exogenous dextran (Figure 1H-I).
There is no observable EC apoptosis during this process (Video
S1) and stabilized EC networks can been maintained in culture for
several weeks (data not shown). Both primary human microvas-
cular endothelial cells (HuMVEC) and primary human umbilical
cord vein endothelial cells (HUVEC) formed indistinguishable
networks in co-culture with vSMC (Figure 2A-B). Endothelial
Figure 2. Endothelial- mesenchymal stem cell co-culture generates capillary-like networks. (A) Live cell fluorescence microscopy whole
well image 9611 montage of RFP-expressing HUVEC - GFP-expressing human dermal microvascular endothelial cell (HuMVEC) – PA-vSMC (unlabeled)
tri-culture network at Day 6 (10X objective) (B) Live cell fluorescence microscopy image 9611montage of interdigitating HUVEC (RFP, red) and
HuMVEC (GFP, green) Day 6 tri-culture with vSMC (406objective). (C) Hoechst nuclear staining of a Day 5 co-culture showing the GFP-expressing
endothelial network (green) amid a confluent PA-SMC layer (blue). (D) Confocal microscopy analysis of anti-a-SMA-stained PA-SMC (green) extending
filopodia that co-localize with multiple RFP-expressing HUVEC (red) in the vessel-like network. (E) Live cell fluorescence microscopy of GFP-expressing
HuMVEC capillary-like network after 5 days in co-culture with PA-vSMC. (F) Live cell fluorescence microscopy of GFP-expressing HUVEC capillary-like
network after 5 days in co-culture with primary human bone marrow-derived mesenchymal stem cells (MSC). Comparison of GFP-expressing HUVEC
co-cultured with PA-SMC (G) and GFP-expressing HUVEC co-cultured with primary human foreskin fibroblast cells (H). Image analysis shows that HFF
are unable to support endothelial network formation (I).
doi:10.1371/journal.pone.0005798.g002
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vSMC (Figure 2C). Confocal microscopy analysis shows that
vSMC extend filopodia that co-localize with multiple endothelial
cells at various points both above and below the focal plane
(Figure 2D). Endothelial networks could also be induced by co-
culture with human bone marrow-derived mesenchymal stem cells
(Figure 2E-F). In contrast, normal human dermal fibroblasts did
not support network formation in co-culture with EC (Figure 2G-
I). This indicates that the mural cell-defined context provides a
specific set of signals to drive the formation of a stable mature
capillary-like network.
ECs co-cultured with vSMCs quiesce, undergo Rac1-
dependent morphogenesis and form adherens junctions
during network formation
Time-lapse fluorescence microscopy analysis of GFP-expressing
EC in co-culture revealed no apparent cell division (Video S1).
Analysis of BrdU-incorporation in EC-vSMC co-culture demon-
strated that while vSMCs divide in co-culture until confluent, ECs
show low BrdU-levels (Figure 3A-C). Indeed, over-expression of
the cell cycle inhibitor p21 in ECs did not affect network formation
(Figure 3D-E). Co-cultured ECs display a polarized, migratory
phenotype during network formation (Figure 3F). Expression of
dominant negative Rac1 (Rac1N17) strongly inhibited morpho-
genesis and network formation emphasizing the importance of
Rac1-dependent cytoskeletal rearrangements (Figure 3G).
Adherens junctions represent the major class of homotypic
endothelial cell-cell interactions [30]. VE-cadherin is a specific
marker for vascular endothelial cells adherens junctions, and
immunofluorescence analysis demonstrated extensive VE-cad-
herin-catenin complex formation in co-culture induced EC
networks (Figure 4A-B). Notably, VE-cadherin complex structures
displayed a distinct ‘‘lacelike’’ appearance in co-cultured EC,
perhaps due to increased interdigitation and junctional tightening
(Figure 4C) [31]. The functional significance of adherence junction
formation in network formation was ascertained by RNAi
Figure 3. Vascular smooth muscle cells inhibit endothelial cell proliferation and drive Rac1-dependent morphogenesis. (A) GFP-
expressing HUVEC grown in mono-culture exhibit extensive BrdU-incorporation (red). (B) In constrast, co-cultured GFP-expressing HUVEC do not
incorporate BrdU, while PA-vSMC SMC divides until confluency. (C) Flow-cytometry analysis showed that HUVEC cells in co-culture have a 4.4-fold
decreased proliferation activity compared to a HUVEC mono-culture. Data shown is representative of three individual experiments. (D) Over-expression
of the cell cycle inhibitor p21 (GFP-p21) in co-cultured HUVEC did not affect EC network formation relative to GFP-expressing HUVEC control (E). (f) A
representative GFP-expressing HUVEC in co-culture at 24 hours post-seeding showing a cell migratory morphology (scalebar=50 mm). (G) Over-
expression of dominant negative Rac1 (GFP-Rac1N17) in co-cultured HUVEC potently inhibited cell morphogenesis and EC network formation.
doi:10.1371/journal.pone.0005798.g003
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delineate the border of interdigititated HUVEC cells (green) in 6 day capillary-like networks. (B) Confocal imaging (collapsed z-stack) of a network
branch point where VE-cadherin immunofluorescence defines borders of layered, intersecting endothelial cells. (C) VE-cadherin immunofluorescence
showed a lace-like structure. (D) Retroviral vector shRNA-mediated knockdown of a-catenin in co-cultured HUVEC results in inhibition of network
formation. Data shown is representative of three independent shRNAs targeting a-catenin. (E) Control shRNA expressing co-cultured HUVECs
generate a capillary-like network. (F) Image analysis of fluorescence microscopy images showed a 2-fold increase in distinct HUVEC (segments)
detected at 72 hours post co-culture seeding.
doi:10.1371/journal.pone.0005798.g004
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an shRNA targeting a-catenin failed to generate an interconnected
capillary-like network in co-culture, instead forming single,
elongated, unconnected ECs that were stable (Figure 4D). a-
catenin knockdown in HUVEC did not alter quiescence or
enhance cell death in co-culture (data not shown). Thus homotypic
EC connectivity via adherens junction formation is separable from
vSMC-induced endothelial quiescence and morphogenesis.
Together these results indicate that while formation of a single
interconnected network relies on the formation of EC-EC
adherens junctions, these junctions are not required for the
endothelial cells to undergo extensive and stable changes in cell
morphology.
ECs co-cultured with vSMCs form vascular basement
membrane-like structures
Formation of the vascular basement membrane is a hallmark of
vessel maturation [3]. We therefore interrogated EC-vSMC co-
cultures for the presence of basement membrane matrix protein
deposition. Confocal immunofluorescence analysis demonstrated
the presence of extensive collagen IV protein structures that
completely ensheathed EC networks at 72 hours (Figure 5A-B).
Collagen IV was not expressed by SMCs or ECs in monoculture
(data not shown), suggesting an induced synthesis and local
collagen IV deposition in co-culture. Collagen XVIII, a specific
constituent of vascular basement membranes showed a similar
peri-endothelial enriched localization pattern in co-culture
(Figure 5C). Other ECM proteins, laminin (Figure 5D) and
fibronectin (data not shown) localized at the vSMC layer. Laminin
expression increased over time in the EC-vSMC co-culture
(Figure 5E).
To determine whether the formation of a collagen-rich vascular
basement membrane-like structure was necessary to stabilize EC
capillary-like networks, co-cultures were treated with a proline
hydroxylase inhibitor (EDBH) or starved for ascorbic acid to
inhibit collagen assembly and synthesis respectively (Figure 5F-J).
These treatments strongly reduced EC-associated collagen depo-
sition, disrupting EC connectivity, reducing tube length and
abrogating EC networks (Figure 5J). Hence formation of a vSMC-
induced vascular basement-like structure contributes to the overall
EC network stability.
ECs require VEGF-R2 and vSMC-associated VEGF to form
a capillary-like network
Previous studies demonstrated the requirement for VEGF to
drive endothelial network formation in different systems including
EC-vSMC co-cultures [22,32]. Indeed, network formation in EC-
vSMC co-cultures is strongly inhibited by treatment during the
initial 48 hours with different VEGF-signaling inhibitors
(Figure 6A-C). Further, shRNA-mediated knockdown of VEGF-
R2 in ECs blocked network formation (Figure 6D; Figure S1).
Timelapse video fluorescence microscopy of PTK787/ZK-treated
co-cultures demonstrated that ECs continue to migrate but do not
elongate nor form EC-EC junctions (Video S3). This is congruent
with the notion that ECM proteins alone are sufficient to induce
cell migration but vSMC-VEGF induced signaling via endothelial
VEGF-R2 is required for network formation [23].
As co-cultures conducted in growth factor-rich or poor (i.e. 2%
serum only) conditions both displayed network formation (data not
shown), we reasoned that VEGF was provided by vSMCs. Indeed,
RT-PCR (Figure S2) and ELISA (Figure 6J) on cultured vSMCs
demonstrated that VEGF165 is a predominant isoform, expressed
at 135 pg/ml per 700 000 cells/day. shRNA-mediated knock-
down of vSMC VEGF-expression (3.5 pg/ml per 700 000 cells/
day) completely blocked EC capillary-like network formation
(Figure 6F). Similarly, vSMC isolates that do not secrete
VEGF165 (,3 pg/ml per 700 000 cells/day) also do not support
EC network formation (Figure 6E). Importantly, the inhibitory
effects of vSMC-VEGF knockdown on network formation
phenotype could not be rescued by co-culture in optimal
endothelial growth medium that contains VEGF, bFGF and
EGF (EGM-2 medium) nor by addition of conditioned native
vSMC medium (Figure 6E-F; data not shown), conditions that
readily support migration and proliferation of EC cultures.
Conversely, we over-expressed VEGF165 in vSMC (3238 pg/ml
per 700 000 cells/day) by retroviral transduction and evaluated
the effects on EC in co-culture. As shown in Figure 6G these EC-
vSMC
VEGF-High co-cultures displayed normal network formation.
Interestingly, retroviral vector expression of VEGF165 in
fibroblasts was insufficient to drive the EC capillary-like network
formation observed for vSMC-EC co-cultures, instead inducing
EC morphology changes characterized by extended filopodia
(Figure 6H-I). These results demonstrate that vSMC-associated
VEGF is required to drive EC capillary-like network formation
and that enhancing this expression does not lead to the formation
of an excessive or less mature EC network. This indicates that
mural cells can define a context that limits the extent of VEGF-
induced angiogenesis and promotes the formation normal vessels.
Discussion
Mural cells exert a dominant effect on endothelial cell behavior
that is necessary for vessel maturation and function, and that
determines responses to anti-angiogenic therapeutics [2,3]. We
report here that primary human mesenchymal cell types, vascular
smooth muscle and mesenchymal stem cells, induce functional and
morphological changes in primary endothelial cells (HUVEC,
HuMVEC) that lead to a uniform, stabilized capillary-like
structure, enveloped by vascular basement membrane matrix
proteins and maintaining a patent lumen, hence recapitulating
major structural components of blood vessels in a high
throughput-high content imaging compatible format.
Mural cell interactions attenuate endothelial proliferation, a
prerequisite for maturation and stability. Reduced mural cell
recruitment to sprouting endothelial cells is associated with vessel
hypertrophy in vivo [8]. Studies employing in vitro co-culture
systems demonstrated that mesenchymal cells induce endothelial
quiescence by direct cell-cell contact, mediated in part by
activation of TGFb [18,24]. Congruent with these reports we
demonstrate that EC proliferation is inhibited in co-culture with
vSMC and that enforced cell cycle arrest by p21 cyclin-dependent
kinase inhibitor expression has no effect on endothelial network
formation. Instead endothelial cells become highly migratory and
morphogenic in the presence of mesenchymal cells. Time-lapse
fluorescence confocal microscopy analysis shows that endothelial
cells engage in extensive pathfinding-activity during the first
72 hours, forming motile cell trains that integrate into fully
interconnected anastamosed endothelial networks.
Several studies using various in vitro angiogenesis systems (e.g.
co-culture, 3-D collagen, Matrigel) have shown that VEGF is
required for endothelial cell network formation [22,32]. Consistent
with this, treatment with a VEGFR tyrosine kinase inhibitor
(PTK787/ZK), RNAi knockdown of endothelial VEGF-R2 or
vSMC-VEGF expression completely abrogates co-culture-induced
endothelial network formation. Time-lapse fluorescence videomi-
croscopy analysis of PTK787/ZK-treated co-cultures demonstrat-
ed that EC remain viable and actively migrate, likely due to vSMC
Mural Cell VEGF
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elongate or form stable cell-cell contacts. VEGF activates Rho-
family small GTPases that induce endothelial cytoskeletal
rearrangements that are required for cell elongation and vessel
formation [25,33]. Indeed, we show that expression of dominant
negative Rac1 potently inhibits EC morphology changes in co-
culture with vSMC. In contrast, targeted disruption of adherens
junction formation via shRNA knockdown of endothelial a-
Figure 5. Endothelial cell networks are stabilized by basement membrane protein deposition. (A) Collagen type IV (red) is deposited at
GFP-expressing HUVEC cells in co-cultures, completely enveloping the endothelial cells (confocal Z-stack, inset). (B) Collagen type IV and (C) collagen
type XVIII have similar EC-associated deposition patterns. (D) SMC-associated laminin expression, 1006objective. (E) Western blot analysis shows that
laminin deposition increases during co-culture. (F) Immunofluorescence analysis of collagen IV (red) expression in 72 hour vehicle-treated co-cultures
with GFP-expressing HUVEC cells and PA-vSMC (unlabelled). (G) Inhibition of collagen type IV synthesis/maturation by EDBH treatment reduces
collagen IV deposition and tube formation. (H) Quantification shows that EDBH-treatment reduces EC network tube average length. (J) Co-cultures
incubated in ascorbic acid-deficient medium inhibited EC network formation compared to control (I).
doi:10.1371/journal.pone.0005798.g005
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cell network, however without influencing EC elongation.
Assembly of the laminin and collagen IV-rich vascular basement
membrane is a critical event in stabilizing newly formed blood vessel
[23]. This peri-endothelial matrix requires proteins from both EC
and mural cells to form and is hence a key result of mural-EC
interactions. We show that important aspects of the basement
membrane assembly are uniquely recapitulated in vSMC-EC co-
culture: In particular, the induction and local deposition of collagen
IV and vascular-specific collagen XVIII that completely ensheaths
Figure 6. Vascular smooth muscle cell-derived VEGF is required for endothelial capillary-like network formation. (A) Fluorescence
microscopy image of GFP-expressing HUVEC and PA-vSMC co-cultures at day 3 post-seeding. Treatment of EC-vSMC co-cultures with VEGF blocking
antibody (Avastin, B) or small molecule VEGFR inhibitor (PTK787/ZK, C) block EC network formation. (D) Transduction of HUVEC with a shRNA
targeting VEGFR-2 retroviral vector also strongly inhibited network formation. (E) A human PA-vSMC isolate (NNW) that has very low VEGF production
and secretion does not support EC network formation. (F) shRNA-mediated knockdown of VEGF levels in human PA-vSMC inhibits network formation.
(G) Overexpression of VEGF165 in PA-vSMC did not affect EC network formation. (H) SV40-immortilized mouse embryonic fibroblasts (SV40-MEF) were
unable to drive EC network. (I) HUVEC cells co-cultured with SV40-MEF cells that overexpress VEGF165 form incomplete networks. (J) ELISA
quantification of VEGF levels from different vSMC cells.
doi:10.1371/journal.pone.0005798.g006
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marked increase in vSMC laminin expression, which may also
contribute to the quiescence of EC [23]. Basement membrane
assembly entails collagen IV incorporation into laminin polymers via
nidogens [34]. Importantly we demonstrate that this matrix protein
structure is functionally significant as inhibitors of collagen synthesis
block network formation. Hence the vSMC-EC co-culture system
represents a novel in vitro model to study vascular basement
membrane assembly.
We demonstrate a singular requirement for mural cell-derived
VEGF in generating a stable capillary-like network formation.
RNAi knockdown of smooth muscle cell VEGF expression
phenocopied the effect of VEGF signaling inhibitors. Surprisingly,
neither the presence of VEGF, bFGF, EGF (EGM-2 medium) nor
conditioned vSMC medium rescued the loss of SMC VEGF
expression. This indicates that VEGF must be associated with the
smooth muscle cells in a specific context in order to trigger EC
morphogenesis. VEGF165, the major isoform expressed by
vSMC, is retained at the cell surface by binding heparin sulfate
proteoglycans (HSPG) [26]. HSPG-bound VEGF165 activates
VEGF-R2 and the co-receptor Nrp1, generating a unique VEGF-
R2 signaling cascade [35], a plausible mechanism for this vSMC-
association dependent signaling. We show that overexpression of
VEGF165 in vSMCs did not affect EC network formation
suggesting that the mural-VEGF presentation context is saturable
and unaffected by pathological VEGF levels that can lead to
abnormal blood vessels and hemangiomas [36].
Mural cells have been shown to express VEGF in vivo [26,37].
VEGF and other growth factors are found at interdigitations
between endothelial cells and mural cells, a unique context for
mural cell-associated VEGF presentation [12]. Growth factor
receptor crosstalk is an important mechanism regulating EC-
pericyte interactions [10]. D’Amore and colleagues suggested that
pericyte-expressed VEGF may serve to transiently stabilize nascent
vessels during basement membrane assembly and lumen forma-
tion via juxtacrine VEGF signaling and heterotypic cell-cell
contact that replaces tissue-derived VEGF (e.g. from astrocytes in
the developing retina) [26]. This switch from tissue-derived to
mural cell-derived VEGF could promote vessel maturation and
ultimately lead to VEGF-independence. Indeed, mural cell
maturation factors, in particular Ang1, have been shown to
abolish endothelial VEGF responsiveness to tissue-derived VEGF
[16,18]. Modulating Ang-Tie2 signaling (by either gain- and loss
of function) did not affect network formation in EC-vSMC co-
culture (data not shown). Together with our observation that
soluble VEGF cannot substitute for mural cell-expressed VEGF
this supports the notion that these VEGF presentation forms are
functionally distinct [35]. Our recent results indicate that the
vSMC co-culture-context leads to altered endothelial cell VEGF-
receptor signaling and that this is necessary to achieve a stable
capillary-like network (Evensen et al., in preparation).
In conclusion, our findings emphasize a unique role for mural
cell-derived VEGF in driving blood vessel maturation and define
an informative high throughput-high content imaging-compatible
experimental system for studying blood vessel formation.
Materials and Methods
Cell culture
Human umbilical vein endothelial cells (HUVEC), pulmonary
artery smooth muscle cells (Pa-vSMC), human adult dermal
microvascular endothelial cells (HUMVEC) and human mesen-
chymal stem cells (hMSC) were purchased from Lonza (C2517A,
CC2581, CC2543, PT2501). To simplify imaging, early passage
HUVEC cells were infected with retrovirus carrying a GFP or
RFP-expressing construct. Cells were maintained in culture in the
supplier’s recommended complete medium (EGM-2, SmGM-2,
EGM-2MV and MSCGM respectively) at 37uC, 5% CO2. The
growth medium was changed every third day and cells were
passaged prior to reaching confluence. The maximum passage
number used for experiments was 8 (HUVEC), 12 (PaSMC), 8
(HUMVEC), 6 (hMSC). Primary human foreskin fibroblasts were
provided by Dr. Ola Hammarsten, Sahlgrenska University
Hospital, Gothenburg, Sweden. SV-40 immortalized mouse
embryonic fibroblasts were provided by Prof. Donald Gullberg,
University of Bergen, Norway.
EC-mural cell co-culture assay
PaSMC and HUVEC were seeded together, centrifuged briefly
at 200 g to achieve an even distribution of cells and cultured in
EGM-2 for at least 72 hrs to allow network formation. For longer
periods, culture medium was changed every third day. Cell
numbers and culture volume were as follows (per well): 96-well
plates: 5610
4 PaSMC, 10610
3 HUVEC, 200 ml EGM-2; 6-well
plates: 8610
5 PaSMC, 1.5610
5 HUVEC, 2 ml EGM-2; trans-
wells: 1.75610
5 PaSMC, 6610
3 HUVEC, 1 ml EGM-2; 8-well
chamber slides: 1.4610
5 PaSMC, 3610
4 HUVEC, 250 ml EGM-
2. HUMVEC and hMSC experiments were conducted similarly
using EGM-2MV as the culture medium.
Microscopy and High content imaging
Confocal images were acquired on a Zeiss LSM 510 Meta. A
Zeiss Axiovert S100 fluorescence microscope with a Roper
Quantix digital camera was used for conventional fluorescence
and brightfield microscopy. For quantitative analysis of the co-
cultures a BD Pathway 855 bioimaging system (BD Biosciences,
San Jose, Ca) was used for automated high throughput imaging.
Statistical analysis of acquired images was done with BD Image
Data Explorer software. Images were acquired as 363 montages
using a 106lens. Background subtraction, noise reduction (rolling
ball) and image thresholding were performed using the AttoVision
v1.6.1 software supplied by BD Biosciences. Statistics on tube
branch lengths, and number of branch points per region of interest
were obtained using the ‘‘Tube Formation’’ image analysis module
of AttoVision v1.6.1. Tube total length is the total number of pixels
comprising the network in the image field. Tube average length is the
total number of pixels comprising the network in the image field
divided by number of unconnected tube segments. Number of
segments is the number of unconnected segments in the image field.
Immunohistochemistry
BrdU staining. BrdU (10 mM) was added 4 hrs after seeding
cells and incubated overnight. Cultures were trypsinated, fixed
(1.6% PFA, 25 mins, room temperature) and permeabilized
(100% methanol, 2 hrs, 4uC). BrdU was visualized by staining
with monoclonal anti-BrdU (Sigma, B8434, 1:500 dilution in
PBS/2% FBS) followed by an allophycocyanin conjugated goat
anti-mouse IgG secondary (Molecular Probes, A865, 1:3000
dilution). BrdU staining was quantified by flow cytometry (10
000 events) on a FACSCalibur (BD Biosciences) and performed as
three independent experiments.
VE-cadherin staining. Cells in 8-well chamber slides were
washed (PBS), fixed (4% PFA, 25 minutes, room temperature) and
permeabilized and blocked (PBS/0.3% Triton X100/5% normal
goat serum, 1 hr, room temperature). VE-cadherin was visualized
with rabbit anti-VE-cadherin antibody (Santa Cruz
Biotechnology, SC9989, 1:200 in PBS/0.3% Triton X100/2%
FBS, overnight, 4uC). Cells were washed (PBS, 365 mins), treated
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conjugated goat-anti-rabbit IgG, 1:3000, 2 hrs, room temperature
in the dark) and washed again (PBS, 365 mins).
Extracellular matrix staining. As for VE-cadherin staining
using primary antibodies diluted 1:200 in PBS/2% FBS and
secondary antibodies diluted 1:3000 in PBS/2% FBS (Molecular
Probes, A21123, Alexa546-conjugated goat anti-mouse IgG).
Primary antibodies were: Monoclonal mouse anti-Collagen type
IV antibody (Chemicon; MAB3326), rabbit anti-Laminin
(Chemicon; AB19012), and monoclonal mouse anti-collagen
type XVIII (a kind gift from Ritva Heljasvaara and Taina
Pihlajaniemi, University of Oulu, Finland).
Lectin staining. Cells were fixed with 4% PFA as above.
HUVEC in co-culture were selectively stained with FITC/
TRITC-UAE 1 lectin (Sigma; L9006/L4889, 1:1000 dilution in
PBS, 45 minutes, room temperate in the dark) and washed (PBS,
365 mins).
Dextran staining. Mature day 8 co-cultures were incubated
with Texas Red-conjugated 10,000 MW dextran (Molecular
Probes, D1828, 0.5 mg/ml, overnight).
RNA interference
RNA interference was achieved using retrovirally expressed
shRNAs. Complementary shRNA oligos (PAGE purified, TAGC
Copenhagen) were annealed and ligated into the MMLV-derived
retroviralshRNAexpressionvectorL071 RRI-GreenorL087 RRI-
Red (Entrez:EU424172, EU424173). These vectors also express a
puromycin resistance marker and GFP or RFP respectively.
Transduced cells were isolated by FACS utilizing fluorescent
protein reporter expression. Final hairpin sequences were:
a -catenin shRNA
GCAGATGTCTACAAATTACTTGTTCAGCTctggtcAGC-
TGAACAAGTAATTTGTAGACATCTGC
VEGFR-2 shRNA oligo
GAACATTTGGGAAATCTCTTGCAAGCTAgaagcttgTAG-
CTTGCAAGAGATTTCCCAAATGTTC
VEGF shRNA
GTGGTGAAGTTCATGGATGTCTATCAGCGctggtcCG-
CTGATAGACATCCATGAACTTCACCAC
GFP, RFP, VEGF, RacN17 and p21 overexpression
Overexpression of proteins in cells was performed by transfec-
tion of a 293T packaging cell line with a retroviral expression
vector containing the DNA of interest. Virus was harvested 24–
48 hrs after transfection in medium suited for the target cells.
Infection was performed by filtering the virus containing medium,
addition of proteamine sulphate, and transferring of the virus
containing medium to the target cells which were incubated
further for 24 hrs. Infection was ended by changing the medium.
Protocol will be given out by request. GFP was expressed from
pCGFP [38]. RFP was expressed from pCtdTomato, a derivative
of pCGFP with the GFP replaced by tdTomato [39]. RacN17 and
p21 were expressed from IRES-GFP retroviral vector [38]. VEGF
was co-expressed with GFP and a puromycin resistance marker
using a 2A-mediated expression system[40].
Quantification of VEGF
VEGF in cells and culture medium was quantified using an
ELISA kit (R&D systems, Human VEGF QuantiGlo Elisa,
QVE00B) and a HIDEX Plate Chameleon luminometer. Samples
were prepared as follows: Culture medium from 24 hrs was
collected, cell debris removed by centrifugation and samples were
stored at 280uC after addition of protease inhibitors (Roche,
Complete Protease Inhibitor Cocktail tablets, 11697498). Cells
were treated with lysis buffer containing 20 mM Tris (pH 8.0),
150 mM NaCl, 1 mM dithiothreitol, 1% deoxycholic acid, 0.5%
sodium dodecylsulfate, 1% Nonidet P-40, and protease inhibitors.
Prior to freezing of samples small aliquots were taken out to
determine protein concentration.
Drug treatment of co-cultures
300 mM ethyl-3–4-dihydroxybenzoate (EDBH, Sigma, E24859-
5G) was added to the cell suspension before plating and treatment
was continued for 72 hrs. Avastin [41] was added identically to a
final concentration of 1 mg/ml. PTK787/ZK222584 [42] (On-
cology Research, Novartis Institutes for BioMedical Research), a
potent inhibitor of vascular endothelial growth factor (VEGF)
receptor tyrosine kinases and class III kinases (platelet-derived
growth factor (PDGF) receptor beta tyrosine kinase, c-Kit, and c-
Fms), was dissolved in dimethyl sulfoxide (DMSO) at a stock
concentration of 10 mM and added to co-cultures at a
concentration of 100 nM.
Supporting Information
Figure S1 Retroviral shRNA knockdown in primary endothelial
cells. (a) Cell lysates from HUVEC mono-cultures transduced with
luciferase shRNA or a-catenin shRNA were analysed by 10%
SDS-PAGE and show knock-down of the 102 kDa protein a-
catenin. Actin, 42 kDa, was used as a loading control. Results are
representative of 3 different shRNA sequences that silence human
a-catenin expression. Each of these different a-catenin shRNA
sequences engendered the non-branching phenotype shown in
Figure 4d. (b) HUVEC transduced with luciferase shRNA or
VEGFR-2 shRNA grown in mono-culture were recovered and
surface stained for VEGFR-2 levels. HUVEC transduced with
VEGFR-2 shRNA (red) show greatly decreased surface levels of
VEGFR-2 compared with luciferase shRNA transduced HUVEC
(green).
Found at: doi:10.1371/journal.pone.0005798.s001 (0.09 MB
PDF)
Figure S2 Dominant VEGF isoforms in PA-vSMC. RT-PCR
analysis of mRNA isolated from monocultured PA-vSMC. Primers
used for nested PCR, VEGF outer: 59-GGGCAGAATCAT-
CACGA-39 (156–172) and 59-CCGCCTCGGCTTGTCACA-39
(629–612) VEGF inner: 5-9ATCGAGACCCTGGTGGACA-39
(219–238) and 59-CCGCCTCGGCTTGTCACA-39 (629–612).
The brackets indicate the positions of primers (Entrez: M32977).
Expected sizes of cDNA fragments for the various vascular growth
factor (VEGF) transcript alternative splice variants when amplified
with outer/or the inner primer pairs: VEGF206 (597 bp/534bp);
VEGF189 (546 bp/483 bp); VEGF165 (474bp/411bp);
VEGF145 (414 bp/351bp); and VEGF121 (342 bp/279 bp).
Found at: doi:10.1371/journal.pone.0005798.s002 (0.09 MB
PDF)
Video S1 Time-lapse microscopy analysis of endothelial-mural
cell co-culture. Co-cultures (GFP-expressing HUVEC and PA-
vSMC) were seeded in 96-well plates and images were acquired
every 15th minute on a Zeiss LSM 510 Meta (37uC, 5% CO2).
Several time-lapse movies from different timepoints were merged
and together span a time range from day 0 to day 9.
Found at: doi:10.1371/journal.pone.0005798.s003 (4.33 MB
MOV)
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PLoS ONE | www.plosone.org 10 June 2009 | Volume 4 | Issue 6 | e5798Video S2 Time-lapse microscopy analysis of a mature endothe-
lial-mural cell co-culture Co-cultures (GFP-expressing HUVEC
and PA-vSMC) were seeded in 96-well plates and images were
acquired every 15th minute on a Zeiss LSM 510 Meta (37uC, 5%
CO2). Time-lapse is recorded from 216–240 hrs post-seeding of
culture and shows a mature quiescent network.
Found at: doi:10.1371/journal.pone.0005798.s004 (0.33 MB
MOV)
Video S3 Time-lapse microscopy analysis of PTK787/ZK-
treated endothelial-mural cell co-culture Co-cultures (GFP ex-
pressing HUVEC) were seeded in a 96-well plate and treated with
100 nM PTK787/ZK. A time-lapse was recorded overnight
(37uC, 5% CO2) by imaging the cells every 15th minute using a
Zeiss LSM 510 Meta.
Found at: doi:10.1371/journal.pone.0005798.s005 (0.29 MB
MOV)
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